Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
The protein encoded by MGP is secreted and likely acts as an inhibitor of bone formation. De plus, nous expédions Matrix Gla Protein Anticorps (60) et Matrix Gla Protein Protéines (29) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 39 products:
Human MGP Kit ELISA pour Sandwich ELISA - ABIN367214
Najafi, Roustazadeh, Amirfarhangi, Kazemi: Matrix Gla protein (MGP) promoter polymorphic variants and its serum level in stenosis of coronary artery. dans Molecular biology reports 2014
Show all 3 references for ABIN367214
Mouse (Murine) MGP Kit ELISA pour Sandwich ELISA - ABIN857742
Wang, Chen, Zhang, Yu, Zhang, Gong, Shao, Lu, Gao, Chen, Chen, Hui: Common genetic variants of MGP are associated with calcification on the arterial wall but not with calcification present in the atherosclerotic plaques. dans Circulation. Cardiovascular genetics 2013
Show all 2 references for ABIN857742
Usefulnees of nonmammalian model systems to elucidate the complex regulation of MGP gene transcription.
These data also indicate that MGP is under dual regulation by runx2 (Montrer RUNX2 Kits ELISA) through the use of various isoforms and context-dependent formation of transcriptional complexes.
MGP is a multi-functional inhibitor of normal and abnormal angiogenesis that may function by coordinating with both Notch and BMP signaling pathways
In contrast with results obtained for previously studied marine fishes, in zebrafish and Senegal sole Mgp accumulates in both calcified tissues and non-mieralized vessel walls of the vascular system.
The substitution of threonine by alanine due to MGP exon 4 Thr83Ala polymorphism is related to a decrease in the likelihood of arterial calcification in female persons in the Ukrainian population
Correlations of plasma desphosphorylated uncarboxylated matrix Gla protein (dp-ucMGP) with vascular calcification and vascular stiffness in chronic kidney disease. Plasma dp-ucMGP was positively associated with vascular calcification and might be utilized as an early marker for vascular calcification in CKD patients.
It is assumed that Lp-PLA2 (Montrer Lp-PLA2 Kits ELISA) is involved in vascular calcification and that dp-ucMGP is a more appropriate biomarker of residual risk than Lp-PLA2 (Montrer Lp-PLA2 Kits ELISA) itself.
Data shoed increased GAS6 (Montrer GAS6 Kits ELISA) and decreased MGP levels in hemodialysis patients, as mediators of induction or prevention of vascular calcification.
Altering NOTCH1 (Montrer NOTCH1 Kits ELISA) levels affected MGP mRNA and protein.
Uncarboxylated MGP in synovial fluid might serve as a novel biomarker for assessing knee osteoarthritis progression.
MGP expression is significantly lower in diseased relative to normal aortic valve interstitial cells. Lack of this important "anti-calcification" protein may contribute to calcification of the aortic valve.
Higher plasma dephosphorylated uncarboxylated MGP (reflective of lower vitamin K status) was associated with higher odds of meniscus damage, osteophytes, bone marrow lesions, and subarticular cysts.
High levels of desphospho-uncarboxylated MGP are independently and positively associated with arterial stiffness after adjustment for common cardiovascular risk factors, renal function, and age.
The association has been found between the ischemic atherothrombotic stroke and polymorphic variants of genes MGP and VKORC1 (Montrer VKORC1 Kits ELISA).
loss of MGP causes dysregulation of early endothelial differentiation.
Matrix Gla protein limits pulmonary arteriovenous malformations in ALK1 (Montrer ACVRL1 Kits ELISA) deficiency.
expression of MGP and OCN increased gradually in the murine developing tibial epiphysis, and the two mineral-associated proteins may occur at the same location during a particular period, but at different levels.
Elastin (Montrer ELN Kits ELISA) haploinsufficiency impedes the progression of arterial calcification in MGP-deficient mice.
The arterial calcification, not MGP deficiency itself, causes the low bone mass phenotype in Mgp-/- mice.
Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 (Montrer TGM2 Kits ELISA) and elastin (Montrer ELN Kits ELISA) fragmentation associated with induction of adipsin (Montrer CFD Kits ELISA).
Mgp gene deletion may have a role in arteriovenous malformations
MGP is a known inhibitor of mineralization, and mice deficient in Mgp show severe vascular calcification and premature bone mineralization.
Inorganic phosphate(Pi) regulates MGP expression in growth plate chondrocytes, thereby suggesting a key role for Pi and ERK1/2 (Montrer MAPK1/3 Kits ELISA) in the regulation of bone formation.
High DNA methylation (Montrer HELLS Kits ELISA) resulting in the down regulation of matrix Gla protein is associated with osteochondrosis.
Selective CaSR (Montrer CASR Kits ELISA) activation, either by extracellular calcium or AMG (Montrer AMELX Kits ELISA) 641, increased MGP expression in vivo in the arterial wall and in vitro in bovine vascular smooth muscle cells.
the effect of MGP on calcification and osteogenic differentiation is determined by availability of BMP-2 (Montrer BMP2 Kits ELISA)
MGP plays a role in endothelial cell function, by increasing transforming growth factor-beta1 activity and stimulating VEGF expression
MGP has a novel binding activity for vitronectin (Montrer VTN Kits ELISA)
Heat shock protein 70 (Montrer HSP70 Kits ELISA) enhances vascular bone morphogenetic protein-4 (Montrer BMP4 Kits ELISA) signaling by binding matrix Gla protein.
The protein encoded by this gene is secreted and likely acts as an inhibitor of bone formation. The encoded protein is found in the organic matrix of bone and cartilage. Defects in this gene are a cause of Keutel syndrome (KS). Two transcript variants encoding different isoforms have been found for this gene.
matrix Gla protein
, Matrix Gla protein
, cell growth-inhibiting gene 36 protein
, matrix gamma-carboxyglutamate (gla) protein